NAVCO Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Geoffrey Lee
Chief executive officer
CA$62.8k
Total compensation
CEO salary percentage | 71.7% |
CEO tenure | 11.6yrs |
CEO ownership | n/a |
Management average tenure | 1.6yrs |
Board average tenure | 1.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | CA$489k |
Mar 31 2024 | n/a | n/a | -CA$3m |
Dec 31 2023 | n/a | n/a | -CA$2m |
Sep 30 2023 | CA$63k | CA$45k | -CA$2m |
Compensation vs Market: Geoffrey's total compensation ($USD44.94K) is below average for companies of similar size in the German market ($USD474.67K).
Compensation vs Earnings: Insufficient data to compare Geoffrey's compensation with company performance.
CEO
Geoffrey Lee
11.6yrs
Tenure
CA$62,775
Compensation
Mr. Geoffrey Lee is Chief Executive Officer of NAVCO Pharmaceuticals Inc. from April 13, 2013.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 11.6yrs | CA$62.78k | no data | |
Chief Financial Officer | 1.6yrs | CA$31.60k | 1.55% € 12.1k | |
COO & Director | 1.6yrs | CA$72.00k | 10.06% € 78.4k | |
Corporate Secretary & Independent Director | 1.6yrs | CA$55.53k | 3.35% € 26.1k |
1.6yrs
Average Tenure
53yo
Average Age
Experienced Management: F0U's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
COO & Director | 1.6yrs | CA$72.00k | 10.06% € 78.4k | |
Corporate Secretary & Independent Director | 1.6yrs | CA$55.53k | 3.35% € 26.1k | |
Independent Director | less than a year | no data | 9.2% € 71.7k | |
Independent Director | less than a year | no data | 9.2% € 71.7k |
1.2yrs
Average Tenure
42.5yo
Average Age
Experienced Board: F0U's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.